Reference : Effect of membrane permeability on survival of hemodialysis patients
Scientific journals : Article
Human health sciences : Urology & nephrology
http://hdl.handle.net/2268/72149
Effect of membrane permeability on survival of hemodialysis patients
English
Locatelli, Francesco [ > > ]
Martin-Malo, Alejandro [ > > ]
Hannedouche, Thierry [ > > ]
Loureiro, Alfredo [ > > ]
Papadimitriou, Menelaos [ > > ]
Wizemann, Volker [ > > ]
Jacobson, Stefan H. [ > > ]
Czekalski, Stanislow [ > > ]
Ronco, Claudio [ > > ]
Vanholder, Raymond [ > > ]
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > > Néphrologie >]
2009
Journal of the American Society of Nephrology
American Society of Nephrology
20
645-654
Yes (verified by ORBi)
International
1046-6673
1533-3450
Washington
DC
[en] The effect of high-flux hemodialysis membranes on patient survival has not been unequivocally determined. In this prospective, randomized clinical trial, we enrolled 738 incident hemodialysis patients, stratified them by serum albumin 4 and 4 g/dl, and assigned them to either low-flux or high-flux membranes. We followed patients for 3 to 7.5 yr. Kaplan-Meier survival analysis showed no significant difference between high-flux and low-flux membranes, and a Cox proportional hazards model concurred. Patients with serum albumin 4 g/dl had significantly higher survival rates in the high-flux group compared with the low-flux
group (P 0.032). In addition, a secondary analysis revealed that high-flux membranes may significantly improve survival of patients with diabetes. Among those with serum albumin 4 g/dl, slightly different effects among patients with and without diabetes suggested a potential interaction between diabetes status and low serum albumin in the reduction of risk conferred by high-flux membranes. In summary, we did not detect a significant survival benefit with either high-flux or low-flux membranes in the population overall, but the use of high-flux membranes conferred a significant survival benefit among patients with serum albumin
4 g/dl. The apparent survival benefit among patients who have diabetes and are treated with high-flux membranes requires confirmation given the post hoc nature of our analysis.
Professionals
http://hdl.handle.net/2268/72149
10.1681/ASN.2008060590

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
2009 JASN 20 645-654.pdfPublisher postprint292.77 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.